Wednesday, November 27, 2024
Home Authors Posts by Editor / Curator

Editor / Curator

928 POSTS 0 COMMENTS
CoronaVirus

Aditxt, (ADTX) Inc. Working on Antiviral Oral Therapy for COVID-19.

Editor / Curator -
CoronaVirus

Up 2,950% is Novavax (NVAX) Still a Buy?

Editor / Curator -
Featured

Alkaline Water Co., (WTER) Announces 33rd Straight Up Quarter.

Editor / Curator -
Biotech News

Resuming Coverage on PetVivo (PETV).

Editor / Curator -
Bitcoin

How to Find 100x Crypto Gems Before Anyone Else (Comtex).

Editor / Curator -
Biotech Stock Review
2021 Watch List

Citius Pharma (CTXR) Flexes Muscle in Business Update. Remains Our Top...

Editor / Curator -
ehave,
Telehealth

Telehealth: Contactless Health Screening from Ehave (EHVVF) and VastMinz.

Editor / Curator -
Drone Stock Review. Draganfly
Drones

Draganfly (DPRO) Shareholder Call Today, 4PM EST.

Editor / Curator -
Biotech Stock Review, DYAI
2020 Watch List

Dyadic (DYAI) Scores $10M deal with Sorrento Therapeutics (SNRE).

Editor / Curator -
Drone Stock Review, Cameron Chell
Drones

Draganfly (DPRO) the Tesla of Drones, Locked and Loaded.

Editor / Curator -
1...404142...93Page 41 of 93

Latest article

Nine Page Summary Report on GeoVax (GOVX)

2024 Watch List Editor / Curator -
This is a great long-term story. We’re telling you. (March 2024) When we finished writing our earlier...

GeoVax (GOVX) Provides First Half 2024 Business Update.

2024 Watch List Editor / Curator -
Award of BARDA Project NextGen contract represents a significant milestone event; Total value...

Reverse Split Mania! Solgenix (SNGX) Jumps 448% After 1:16.

All News Editor / Curator -
Can You Imagine Selling Solgenix at $2.00 yesterday. And to be honest, news wasn't all that big - such...
The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
Contact us: [email protected]
© Managed by Revelers.IO Media Group Inc.